+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infection Control Market Size, Share & Trends Analysis Report by Type (Equipment, Disinfectors, Sterilization Equipment, Services, Consumables), by End Use, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 4312570
The global infection control market size is expected to reach USD 359.6 Billion by 2030. The market is expected to register a CAGR of 6.7% from 2022 to 2030. The market is driven by rising concerns with respect to a significant upsurge in hospital-acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in the development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall market. Healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern.



In addition, an increasing number of intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years. For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and the spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in a wide array of healthcare settings such as ambulatory care, home care, hospitals, and others.

As a consequence of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights. The demand for infection control also stemmed from the need to stop the spread of COVID-19. Governments' authorities prescribed guidelines and policies to safeguard public health and prevent cross-contamination. The CDC, and the U.S. Department of Health and Human Services, provide an extensive library of guidelines on basic infection control and prevention, device-associated infections, antibiotic resistance, disease / organism-specific infection, and procedure-associated infections to promote the control of hospital-acquired infections.

An increase in strategic initiatives undertaken by companies including include strategic partnerships, mergers and acquisitions, and product development are further propelling the market growth. For instance, Getinge expanded its partnership with XPO Logistics under which the latter will provide warehousing and transport services from the Netherlands to the EMEA region for the company’s infection control business unit in February 2021.

Infection Control Market Report Highlights

  • Services are predicted to observe exponential growth as a consequence of the increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost-efficiency.
  • Hospitals accounted for a substantial share in 2021, as a consequence of high clinical urgency to curb the growing incidence of hospital-acquired infections.
  • North America captured a dominant share of the overall market as of 2021 owing to extensive infection prevention activities being implemented in hospitals, medical devices and pharmaceutical companies.
  • The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to the spread of infections within healthcare settings and measures for prevention.
  • The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers and acquisitions resulting in significant growth in their market share.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region-Based Segment Share Calculation
1.3 List Of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 COVID-19 Impact On The Market
3.5 Penetration & Growth Prospect Mapping
3.6 Infection Control Market-SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.7 Industry Analysis-Porter’s Five Forces Model
Chapter 4 Infection Control Market: Type Estimates & Trend Analysis
4.1 Infection Control Market: Type Movement Analysis
4.2 Equipment
4.2.1 Equipment Market, 2017-2030 (USD Billion)
4.2.2 Disinfectors
4.2.2.1 Disinfectors Market, 2017-2030 (USD Billion)
4.2.2.2 Washers
4.2.2.2.1 Washers Market, 2017-2030 (USD Billion)
4.2.2.3 Flushers
4.2.2.3.1 Flushers Market, 2017-2030 (USD Billion)
4.2.2.4 Endoscope Reprocessors
4.2.2.4.1 Endoscope Reprocessors Market, 2017-2030
4.2.3 Sterilization Equipment
4.2.3.1 Sterilization Market, 2017-2030 (USD Billion)
4.2.3.2 Heat Sterilization Equipment
4.2.3.2.1 Heat Sterilization, 2017-2030 (USD Billion)
4.2.3.3 Low-Temperature Equipment
4.2.3.3.1 Low-Temperature Market, 2017-2030 (USD Billion)
4.2.3.4 Radiation Sterilization Equipment
4.2.3.4.1 Radiation Sterilization Estimates and Forecasts, 2017-2030
4.2.3.5 Filtration Sterilization Equipment
4.2.3.5.1 Filtration Sterilization Estimates, 2017-2030 (USD Billion)
4.2.3.6 Liquid Sterilization Equipment
4.2.3.6.1 Liquid Sterilization Market, 2017-2030 (USD Billion)
4.2.4 Others
4.2.4.1 Others Market, 2017 -2030 (USD Billion)
4.3 Services
4.3.1 Services Market Estimates and Forecasts, 2017-2030 (USD Billion)
4.3.2 Contract Sterlization
4.3.2.1 Contract Sterilization Market, 2017-2030 (USD Billion)
4.3.2.2 Ethylene Oxide Sterilization
4.3.2.2.1 Ethylene Oxide Sterilization Market, (USD Billion)
4.3.2.3 E-Beam Sterilization
4.3.2.3.1 E-Beam Sterilization Market, 2017-2030 (USD Billion)
4.3.2.4 Gamma Sterilization
4.3.2.4.1 Gamma Sterilization Market, 2017-2030 (USD Billion)
4.3.2.5 Others
4.3.2.5.1 Others Market, 2017-2030 (USD Billion)
4.3.3 Infectious Waste Disposal
4.3.3.1 Infectious Waste Disposal Market, 2017-2030 (USD Billion)
4.4 Consumables
4.4.1 Consumables Market, 2017-2030 (USD Billion)
4.4.2 Infectious Waste Disposal
4.4.2.1 Infectious Waste Disposal Market, 2017-2030 (USD Billion)
4.4.3 Disinfectants
4.4.3.1 Disinfectants Market, 2017-2030 (USD Billion)
4.4.4 Sterilization Consumables
4.4.4.1 Sterilization Consumables Market, 2017-2030 (USD Billion)
4.4.5 Personal Protective Equipment
4.4.5.1 Personal Protective Market, 2017-2030 (USD Billion)
4.4.6 Others
4.4.6.1 Others Market, 2017-2030 (USD Billion)
Chapter 5 Infection Control Market: End-Use Estimates & Trend Analysis
5.1 Infection Control Market: End-Use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals Market Estimates and Forecasts, 2017-2030 (USD Billion)
5.3 Medical Device Companies
5.3.1 Medical Device Companies Market,2017-2030 (USD Billion)
5.4 Clinical Laboratories
5.4.1 Clinical Laboratories Market, 2017-2030 (USD Billion)
5.5 Pharmaceutical Companies
5.5.1 Pharmaceutical Companies Market, 2017-2030 (USD Billion)
5.6 Others
5.6.1 Others Market Estimates and Forecasts, 2014-2025 (USD Billion)
Chapter 6 Infection Control Market: Regional Estimates & Trend Analysis, by Type & End-Use
6.1 Infection Control Market Shares by Region, 2017-2030 (USD Billion)
6.2 North America
6.2.1 North America Infection Control Market Estimates and Forecasts, 2017-2030 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. Market Estimates and Forecasts, 2017-2030 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada Market Estimates and Forecasts, (USD Billion)
6.3 Europe
6.3.1 Europe Infection Control Market, 2017-2030 (USD Billion)
6.3.2 Germany
6.3.2.1 Germany Infection Control Market, (USD Billion)
6.3.3 U.K.
6.3.3.1 U.K. Infection Control Market, 2017-2030 (USD Billion)
6.3.4 France
6.3.4.1.France Infection Control Market, 2017-2030 (USD Billion)
6.3.5 Italy
6.3.5.1 Italy Infection Control Market, 2017-2030 (USD Billion)
6.3.6 Spain
6.3.6.1 Spain Infection Control Market, 2017-2030 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Infection Control Market, 2017-2030 (USD Billion)
6.4.2 Japan
6.4.2.1 Japan Infection Control Market, 2017-2030 (USD Billion)
6.4.3 China
6.4.3.1 China Infection Control Market, 2017-2030 (USD Billion)
6.4.5 India
6.4.5.1 India Infection Control Market, 2017-2030 (USD Billion)
6.5 Latin America
6.5.1 Latin America Infection Control Market, 2017-2030 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil Infection Control Market 2017-2030 (USD Billion)
6.5.4 Mexico
6.5.4.1 Mexico Infection Control Market 2017-2030 (USD Billion)
6.6 MEA
6.6.1 MEA Infection Control Market, 2017-2030 (USD Billion)
6.6.2.Saudi Arabia
6.6.2.1. Saudi Arabia Infection Control Market, 2017-2030 (USD Billion)
6.6.3 South Africa
6.6.3.1 South Africa Infection Control Market, 2017-2030 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 3M Company
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Belimed
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Halyard Health, Inc.
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Biomérieux SA
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Cantel Medical
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Medical Device Business Services, Inc
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Getinge AB
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 KCWW
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Sterigenics U.S.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 STERIS
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives

Companies Mentioned

  • 3M Company
  • Belimed
  • Halyard Health, Inc.
  • Biomérieux Sa
  • Cantel Medical
  • Medical Device Business Services, Inc
  • Getinge Ab
  • Kcww
  • Sterigenics U.S.
  • Steris

Methodology

Loading
LOADING...